**Core Concept**
Amrinone is a phosphodiesterase-3 inhibitor, which is a class of drugs that play a crucial role in modulating intracellular signaling pathways. By inhibiting phosphodiesterase-3, amrinone increases the levels of cyclic adenosine monophosphate (cAMP) within cardiac cells, leading to increased contractility and relaxation.

**Why the Correct Answer is Right**
Amrinone acts as a phosphodiesterase-3 inhibitor, which means it prevents the breakdown of cAMP by inhibiting the enzyme phosphodiesterase-3. This results in an accumulation of cAMP within cardiac cells, leading to increased contractility and relaxation. The increased levels of cAMP activate protein kinase A (PKA), which in turn phosphorylates and activates various downstream targets, ultimately leading to increased cardiac contractility and relaxation.

**Why Each Wrong Option is Incorrect**
**Option B:** ATPase inhibitors are a class of drugs that inhibit the enzyme ATPase, which is involved in the breakdown of ATP to ADP. Amrinone does not act by inhibiting ATPase, so this option is incorrect.

**Option C:** Calcium channel blockers are a class of drugs that inhibit the influx of calcium ions into cardiac cells, leading to decreased contractility. Amrinone has the opposite effect, increasing contractility, so this option is incorrect.

**Option D:** IC/ channel openers are a class of drugs that activate potassium channels, leading to hyperpolarization of cardiac cells and decreased contractility. Amrinone does not act by activating potassium channels, so this option is incorrect.

**Clinical Pearl / High-Yield Fact**
Amrinone is used in the treatment of heart failure and is particularly useful in patients with refractory heart failure who do not respond to other treatments. It is also used in patients with cardiogenic shock.

**✓ Correct Answer: A. Inhibiting phosphodiesterase**